MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.

MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 3' un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type Adenovirus 5 (Ad5WT) in mice can be prevented...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryan Cawood, Suet-Ling Wong, Ying Di, Dilair F Baban, Leonard W Seymour
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/31b27a319ae14a5fb78d650d87af5e7b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:31b27a319ae14a5fb78d650d87af5e7b
record_format dspace
spelling oai:doaj.org-article:31b27a319ae14a5fb78d650d87af5e7b2021-11-18T07:00:36ZMicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.1932-620310.1371/journal.pone.0016152https://doaj.org/article/31b27a319ae14a5fb78d650d87af5e7b2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21264344/?tool=EBIhttps://doaj.org/toc/1932-6203MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 3' un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type Adenovirus 5 (Ad5WT) in mice can be prevented by incorporating 4 binding sites for the liver-specific microRNA, mir122, into the 3' UTR of E1A mRNA. This virus, termed Ad5mir122, is a promising virotherapy candidate and causes no obvious liver pathology. Herein we show that Ad5mir122 maintains wild-type lytic activity in cancer cells not expressing mir122 and assess any effects of possible mir122 depletion in host cells. Repeat administration of 2×10(10) viral particles of Admir122 to HepG2 tumour bearing mice showed significant anti-cancer efficacy. RT-QPCR showed that E1A mRNA was down-regulated 29-fold in liver when compared to Ad5WT. Western blot for E1A confirmed that all protein variants were knocked down. RT-QPCR for mature mir122 in infected livers showed that quantity of mir122 remained unaffected. Genome wide mRNA microarray profiling of infected livers showed that although the transcript level of >3900 different mRNAs changed more than 2-fold following Ad5WT infection, less than 600 were changed by Ad5mir122. These were then filtered to select mRNAs that were only altered by Ad5mir122 and the remaining 21 mRNAs were compared to predicted mir122 targets. No mir122 target mRNAs were affected by Ad5 mir122. These results demonstrate that the exploitation of microRNA regulation to control virus replication does not necessarily affect the level of the microRNA or the endogenous mRNA targets.Ryan CawoodSuet-Ling WongYing DiDilair F BabanLeonard W SeymourPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 1, p e16152 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ryan Cawood
Suet-Ling Wong
Ying Di
Dilair F Baban
Leonard W Seymour
MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
description MicroRNAs are small non-coding RNA molecules that regulate mRNA translation and stability by binding to complementary sequences usually within the 3' un-translated region (UTR). We have previously shown that the hepatic toxicity caused by wild-type Adenovirus 5 (Ad5WT) in mice can be prevented by incorporating 4 binding sites for the liver-specific microRNA, mir122, into the 3' UTR of E1A mRNA. This virus, termed Ad5mir122, is a promising virotherapy candidate and causes no obvious liver pathology. Herein we show that Ad5mir122 maintains wild-type lytic activity in cancer cells not expressing mir122 and assess any effects of possible mir122 depletion in host cells. Repeat administration of 2×10(10) viral particles of Admir122 to HepG2 tumour bearing mice showed significant anti-cancer efficacy. RT-QPCR showed that E1A mRNA was down-regulated 29-fold in liver when compared to Ad5WT. Western blot for E1A confirmed that all protein variants were knocked down. RT-QPCR for mature mir122 in infected livers showed that quantity of mir122 remained unaffected. Genome wide mRNA microarray profiling of infected livers showed that although the transcript level of >3900 different mRNAs changed more than 2-fold following Ad5WT infection, less than 600 were changed by Ad5mir122. These were then filtered to select mRNAs that were only altered by Ad5mir122 and the remaining 21 mRNAs were compared to predicted mir122 targets. No mir122 target mRNAs were affected by Ad5 mir122. These results demonstrate that the exploitation of microRNA regulation to control virus replication does not necessarily affect the level of the microRNA or the endogenous mRNA targets.
format article
author Ryan Cawood
Suet-Ling Wong
Ying Di
Dilair F Baban
Leonard W Seymour
author_facet Ryan Cawood
Suet-Ling Wong
Ying Di
Dilair F Baban
Leonard W Seymour
author_sort Ryan Cawood
title MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
title_short MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
title_full MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
title_fullStr MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
title_full_unstemmed MicroRNA controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microRNA activity.
title_sort microrna controlled adenovirus mediates anti-cancer efficacy without affecting endogenous microrna activity.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/31b27a319ae14a5fb78d650d87af5e7b
work_keys_str_mv AT ryancawood micrornacontrolledadenovirusmediatesanticancerefficacywithoutaffectingendogenousmicrornaactivity
AT suetlingwong micrornacontrolledadenovirusmediatesanticancerefficacywithoutaffectingendogenousmicrornaactivity
AT yingdi micrornacontrolledadenovirusmediatesanticancerefficacywithoutaffectingendogenousmicrornaactivity
AT dilairfbaban micrornacontrolledadenovirusmediatesanticancerefficacywithoutaffectingendogenousmicrornaactivity
AT leonardwseymour micrornacontrolledadenovirusmediatesanticancerefficacywithoutaffectingendogenousmicrornaactivity
_version_ 1718424031867174912